Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

ANVS

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Annovis Bio, Inc.

Yes. JPMorgan Chase holds 15,219 shares of ANVS (Annovis Bio), worth $28,307, as of its Q2 2026 13F filing. It increased the position by 319 shares (+2.1%) from Q1 2026. JPMorgan Chase has held ANVS in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$28,307

Current Shares

15,219

Total Value Change

-$2,321

Total Shares Change

+11,419

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
15,219
+2.1%
$28,3070.0%$1.86
13
2026-Q1
Unchanged
14,900
0.0%
$29,9490.0%$2.23
0
2025-Q4
Unchanged
14,900
0.0%
$51,5540.0%$3.46
0
2025-Q3
Unchanged
14,900
0.0%
$30,8430.0%$2.07
0
2025-Q2
Increased
14,900
+69.3%
$32,3330.0%$2.17
20
2025-Q1
Increased
8,800
+131.6%
$13,2000.0%$1.50
19
2024-Q4
Unchanged
3,800
0.0%
$19,1140.0%$5.03
0
2024-Q3
First report
3,800
-
$30,6280.0%$8.06
0

Other major holders of ANVS: Voloridge Investment Management, LLC, Adage Capital Partners GP, L.L.C., Marshall Wace, LLP, Geode Capital Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used